D Molecular Therapeutics (FDMT) offers attractive growth potential with strong cash reserves and promising late-stage gene ...
Our tenth annual ranking of independent advisory companies is based on assets managed by the firms, growth, technology spending, succession planning, and other metrics. Barron’s is ranking the largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback